Cervical Cancer Clinical Trials
Cervical Cancer clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for cervical Cancer. Corterve aggregates actively recruiting Cervical Cancer studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Cervical Cancer studies
- Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsNCT06293898PHASE1SystImmune Inc.Endometrial CancerBirmingham, Alabama
- Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerNCT07061977PHASE3National Cancer Institute (NCI)Locally Advanced Cervical AdenocarcinomaBirmingham, Alabama
- A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)NCT07216703PHASE3Merck Sharp & Dohme LLCCervical CancerBirmingham, Alabama
- Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsNCT06814496PHASE1, PHASE2University of ArizonaMelanomaGilbert, Arizona
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersNCT05639972PHASE1, PHASE2Christian HinrichsHPV-Associated Cervical CarcinomaNew Brunswick, New Jersey
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)NCT05579366PHASE1, PHASE2GenmabHigh Grade Epithelial Ovarian CancerPhoenix, Arizona
- Distance-Based Exercise to Preserve Function and Prevent DisabilityNCT07059884NAAlliance for Clinical Trials in OncologyLocalized Malignant Solid NeoplasmDublin, California
- A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsNCT06465069PHASE1Eli Lilly and CompanyMetastatic Solid TumorDuarte, California
- A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsNCT06172478PHASE2Daiichi SankyoAdvanced Solid TumorDuarte, California
- 177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsNCT07189871PHASE1, PHASE2Radiopharm Theranostics, LtdCastration-Resistant Prostate Cancer (CRPC)Dothan, Alabama
- Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)NCT06079671PHASE3AstraZenecaLocally Advanced Cervical CancerBirmingham, Alabama
- Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical CancerNCT05051722Mayo ClinicEndometrial CancerPhoenix, Arizona
Cervical Cancer trials by state
Cervical Cancer trials by metro
Frequently asked questions
- How do I find recruiting Cervical Cancer clinical trials?
- Browse the actively recruiting Cervical Cancer studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Cervical Cancer clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Cervical Cancer clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.